Back to Search
SHI-MING TU, M.D.
M.D.
Medical Oncology Physician
NPI: 1386721421IndividualAccepts Medicare
Education
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1987
Research & Publications (20)
Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy.
PMID 19402048·Cancer·2009
8-other
Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer.
PMID 19414670·J Clin Oncol·2009
3-trial
Activity coupling and complex formation between bacterial luciferase and flavin reductases.
PMID 18264585·Photochem Photobiol Sci·2008
6-review
Noise simulation in cone beam CT imaging with parallel computing.
PMID 16481694·Phys Med Biol·2006
8-other
Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy.
PMID 16258090·J Clin Oncol·2005
8-other
Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features.
PMID 12173328·Cancer·2002
8-other
Stem-cell origin of metastasis and heterogeneity in solid tumours.
PMID 12147437·Lancet Oncol·2002
6-review
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial.
PMID 11210994·Lancet·2001
3-trial
Reduced flavin: donor and acceptor enzymes and mechanisms of channeling.
PMID 11761334·Antioxid Redox Signal·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1155 PRESSLER ST, UNIT 1374
HOUSTON, TX 77030 - Phone
- (713) 792-2830
Quick Facts
- NPI
- 1386721421
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile